GlassScriptPhysician profile
Crystal C Sen
NPI 1235308909
$790.44
in general payments reported to CMS, 2019-2025
16 companies · $15.33 in 2025
The $15.33 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $312 · 2023: $276 · 2024: $55.25 · 2025: $15.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $251.55 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $75.21 | 2022-2024 | Jardiance, Zepbound |
| Abbvie INC. | $74.45 | 2021-2024 | |
| Amgen INC. | $72.57 | 2021-2023 | Enbrel |
| Xeris Pharmaceuticals, INC. | $67.76 | 2023 | Gvoke Hypopen |
| Upsher-Smith Laboratories LLC | $48.83 | 2021-2022 | |
| Glaxosmithkline, LLC. | $40.23 | 2022-2025 | Arexvy, Shingrix |
| Amneal Pharmaceuticals LLC | $21.59 | 2023 | Unithroid |
| Eisai INC. | $20.60 | 2021 | |
| Abbott Laboratories | $19.99 | 2023 | Freestyle Libre 3 |
| Abiomed | $18.51 | 2023 | Impella |
| Fresenius Kabi USA, LLC | $17.38 | 2023 | Idacio |
| Bausch Health US, LLC | $16.11 | 2022 | |
| Astellas Pharma US INC | $15.60 | 2023 | Veozah |
| Dexcom, INC. | $15.04 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Sen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.